JP2014518063A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014518063A5 JP2014518063A5 JP2014513625A JP2014513625A JP2014518063A5 JP 2014518063 A5 JP2014518063 A5 JP 2014518063A5 JP 2014513625 A JP2014513625 A JP 2014513625A JP 2014513625 A JP2014513625 A JP 2014513625A JP 2014518063 A5 JP2014518063 A5 JP 2014518063A5
- Authority
- JP
- Japan
- Prior art keywords
- crosslinker
- peptide
- modified
- igf
- lysosomal enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161490957P | 2011-05-27 | 2011-05-27 | |
| US61/490,957 | 2011-05-27 | ||
| PCT/US2012/039705 WO2012166653A2 (en) | 2011-05-27 | 2012-05-25 | Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017133655A Division JP2017225444A (ja) | 2011-05-27 | 2017-07-07 | リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014518063A JP2014518063A (ja) | 2014-07-28 |
| JP2014518063A5 true JP2014518063A5 (https=) | 2018-02-15 |
| JP6300720B2 JP6300720B2 (ja) | 2018-03-28 |
Family
ID=47260229
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014513625A Active JP6300720B2 (ja) | 2011-05-27 | 2012-05-25 | リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法 |
| JP2017133655A Pending JP2017225444A (ja) | 2011-05-27 | 2017-07-07 | リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017133655A Pending JP2017225444A (ja) | 2011-05-27 | 2017-07-07 | リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9545450B2 (https=) |
| EP (1) | EP2714752B1 (https=) |
| JP (2) | JP6300720B2 (https=) |
| KR (2) | KR20190022943A (https=) |
| CN (2) | CN108586621A (https=) |
| BR (1) | BR112013030432A2 (https=) |
| CA (1) | CA2836318C (https=) |
| CY (1) | CY1120485T1 (https=) |
| DK (1) | DK2714752T3 (https=) |
| ES (1) | ES2660185T3 (https=) |
| HR (1) | HRP20180291T1 (https=) |
| HU (1) | HUE038172T2 (https=) |
| LT (1) | LT2714752T (https=) |
| NO (1) | NO2820016T3 (https=) |
| PL (1) | PL2714752T3 (https=) |
| PT (1) | PT2714752T (https=) |
| RS (1) | RS56913B1 (https=) |
| SI (1) | SI2714752T1 (https=) |
| SM (1) | SMT201800101T1 (https=) |
| TR (1) | TR201802230T4 (https=) |
| WO (1) | WO2012166653A2 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9925303B2 (en) | 2012-11-13 | 2018-03-27 | Edwards Lifesciences Corporation | Methods for cross-linking bioprosthetic tissue using bio-orthogonal binding pairs |
| AU2014228231B2 (en) * | 2013-03-15 | 2019-02-21 | Amicus Therapeutics, Inc. | Chemical crosslinkers |
| US20170121377A1 (en) * | 2014-04-04 | 2017-05-04 | Vestaron Corporation | Artificially activated toxic peptides |
| EP3185889B1 (en) * | 2014-08-11 | 2020-07-15 | Shire Human Genetic Therapies, Inc. | Mannose-6-phosphate bearing peptides fused to lysosomal enzymes |
| CN114540327B (zh) * | 2014-09-30 | 2026-03-24 | 阿米库斯治疗学公司 | 具有增强的碳水化合物的高强度酸性α-葡糖苷酶 |
| CN104356238B (zh) * | 2014-10-15 | 2018-01-09 | 大连理工大学 | 一种重组蛋白a亲和配基的定点固定化方法 |
| HUE045254T2 (hu) * | 2015-03-11 | 2019-12-30 | Ocv Intellectual Capital Llc | Eljárások kipufogódobok szálasanyaggal történõ megtöltésére |
| US11262348B2 (en) | 2015-11-06 | 2022-03-01 | Biomarin Pharmaceutical Inc. | Cell-based assays for detection of antibodies or other factors that neutralize uptake of lysosomal enzymes |
| DK3386534T3 (da) * | 2015-12-08 | 2020-11-30 | Regeneron Pharma | Sammensætninger og fremgangsmåder til internalisering af enzymer |
| DK3635009T3 (da) | 2017-06-07 | 2026-03-30 | Regeneron Pharma | Sammensætninger og fremgangsmåder til internalisering af enzymer |
| CA3066026A1 (en) | 2017-06-14 | 2018-12-20 | Virometix Ag | Cyclic peptides for protection against respiratory syncytial virus |
| CR20200129A (es) | 2017-10-02 | 2020-08-22 | Denali Therapeutics Inc | Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas |
| US12258597B2 (en) | 2018-02-07 | 2025-03-25 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for therapeutic protein delivery |
| US11492610B2 (en) | 2018-03-08 | 2022-11-08 | California Institute Of Technology | Sample multiplexing for single-cell RNA sequencing |
| BR112020021962A2 (pt) | 2018-04-30 | 2021-01-26 | Amicus Therapeutics, Inc. | construtos para terapia gênica e métodos de uso |
| BR112020023145A2 (pt) | 2018-05-17 | 2021-02-02 | Regeneron Pharmaceuticals, Inc. | anticorpo anti-cd63 ou fragmento de ligação ao antígeno do mesmo, molécula de ligação ao antígeno biespecífica, proteína terapêutica de múltiplos domínios, polinucleotídeo composição farmacêutica, e, composto |
| CN113631182B (zh) | 2018-10-10 | 2025-03-21 | 阿米库斯治疗学公司 | 二硫键稳定的多肽组合物和使用方法 |
| WO2020113036A2 (en) * | 2018-11-28 | 2020-06-04 | Promega Corporation | Reactive peptide labeling |
| AU2019404061A1 (en) | 2018-12-19 | 2021-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules for lysosomal targeting and related compositions and methods |
| JP7550762B2 (ja) | 2018-12-20 | 2024-09-13 | ヴァイロメティックス アーゲー | リポペプチドビルディングブロックおよび合成ウイルス様粒子 |
| JP7585233B2 (ja) * | 2019-04-30 | 2024-11-18 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | ポンペ病の治療のために有用な組成物 |
| CN110373405B (zh) * | 2019-07-24 | 2023-12-15 | 杭州恩和生物科技有限公司 | 一种接枝聚合物的生物酶及其制备方法和固定方法 |
| KR20220077921A (ko) * | 2019-10-10 | 2022-06-09 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 변이체 igf2 작제물 |
| EP4216992A1 (en) | 2020-09-28 | 2023-08-02 | DBV Technologies | Particle comprising an rsv-f protein for use in rsv vaccination |
| TW202237850A (zh) | 2020-12-01 | 2022-10-01 | 賓州大學委員會 | 具有組織特異性靶向基序的新穎構成物及含有其之組成物 |
| CA3216004A1 (en) | 2021-04-23 | 2022-10-27 | The Trustees Of The University Of Pennsylvania | Novel compositions with brain-specific targeting motifs and compositions containing same |
| WO2022271981A2 (en) | 2021-06-23 | 2022-12-29 | Lycia Therapeutics, Inc. | Bifunctional compounds containing igf-2 polypeptides |
| EP4370157A1 (en) | 2021-07-14 | 2024-05-22 | Lycia Therapeutics, Inc. | Asgpr cell surface receptor binding compounds and conjugates |
| EP4634394A2 (en) | 2022-12-17 | 2025-10-22 | The Trustees of The University of Pennsylvania | Recombinant aav mutant vectors with cardiac and skeletal muscle-specific targeting motifs and compositions containing same |
| WO2024130070A2 (en) | 2022-12-17 | 2024-06-20 | The Trustees Of The University Of Pennsylvania | Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof |
| TW202516019A (zh) | 2023-06-29 | 2025-04-16 | 賓州大學委員會 | 具中樞神經系統靶向模體的突變aav及含有其之組成物 |
| CN121693342A (zh) | 2023-07-12 | 2026-03-17 | 维罗迈科斯股份公司 | 肺炎球菌抗原的组合物 |
| WO2025106661A1 (en) | 2023-11-14 | 2025-05-22 | The Trustees Of The University Of Pennsylvania | Compositions with cardiac and skeletal musclespecific targeting motifs and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1118334A1 (en) * | 2000-01-11 | 2001-07-25 | Aventis Behring Gesellschaft mit beschränkter Haftung | Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| US7560424B2 (en) * | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| US20030072761A1 (en) | 2001-10-16 | 2003-04-17 | Lebowitz Jonathan | Methods and compositions for targeting proteins across the blood brain barrier |
| US7355018B2 (en) | 2003-09-30 | 2008-04-08 | Regeneron Pharmaceuticals, Inc. | Modified IGF1 polypeptides with increased stability and potency |
| JP5627571B2 (ja) * | 2008-05-07 | 2014-11-19 | バイオマリン ファーマシューティカル インコーポレイテッド | リソソーム標的化ペプチドおよびその使用 |
| ES3000111T3 (en) * | 2009-02-13 | 2025-02-27 | Immunomedics Inc | Intermediates for preparing conjugates with an intracellularly-cleavable linkage |
-
2012
- 2012-05-25 HR HRP20180291TT patent/HRP20180291T1/hr unknown
- 2012-05-25 US US14/122,858 patent/US9545450B2/en active Active
- 2012-05-25 KR KR1020197005833A patent/KR20190022943A/ko not_active Ceased
- 2012-05-25 RS RS20180188A patent/RS56913B1/sr unknown
- 2012-05-25 DK DK12793015.4T patent/DK2714752T3/en active
- 2012-05-25 KR KR1020137034111A patent/KR101955054B1/ko not_active Expired - Fee Related
- 2012-05-25 BR BR112013030432A patent/BR112013030432A2/pt not_active Application Discontinuation
- 2012-05-25 SI SI201231229T patent/SI2714752T1/en unknown
- 2012-05-25 TR TR2018/02230T patent/TR201802230T4/tr unknown
- 2012-05-25 CA CA2836318A patent/CA2836318C/en active Active
- 2012-05-25 ES ES12793015.4T patent/ES2660185T3/es active Active
- 2012-05-25 EP EP12793015.4A patent/EP2714752B1/en active Active
- 2012-05-25 PL PL12793015T patent/PL2714752T3/pl unknown
- 2012-05-25 CN CN201810440498.1A patent/CN108586621A/zh not_active Withdrawn
- 2012-05-25 WO PCT/US2012/039705 patent/WO2012166653A2/en not_active Ceased
- 2012-05-25 CN CN201280037051.0A patent/CN104160033B/zh active Active
- 2012-05-25 HU HUE12793015A patent/HUE038172T2/hu unknown
- 2012-05-25 SM SM20180101T patent/SMT201800101T1/it unknown
- 2012-05-25 PT PT127930154T patent/PT2714752T/pt unknown
- 2012-05-25 LT LTEP12793015.4T patent/LT2714752T/lt unknown
- 2012-05-25 JP JP2014513625A patent/JP6300720B2/ja active Active
-
2013
- 2013-02-25 NO NO13708603A patent/NO2820016T3/no unknown
-
2016
- 2016-11-09 US US15/347,006 patent/US10660972B2/en active Active
-
2017
- 2017-07-07 JP JP2017133655A patent/JP2017225444A/ja active Pending
-
2018
- 2018-02-22 CY CY20181100212T patent/CY1120485T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014518063A5 (https=) | ||
| JP2017225444A5 (https=) | ||
| CA2836318C (en) | Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases | |
| CA2052375C (en) | Parathyroid hormone derivatives | |
| CN101133082B (zh) | 酰化的glp-1化合物 | |
| WO2013065009A1 (en) | A sortase-click reaction suite for synthesis of multivalent dendrimeric protein assembly | |
| JP2015534568A (ja) | Ｉｒｆ５に結合する細胞透過性ペプチド | |
| MX2011000847A (es) | Proteinas conjugadas con eficacia prolongada in vivo. | |
| KR20100014215A (ko) | 신규 단백질 접합체 및 그것의 제조 방법 | |
| CA2635998A1 (fr) | Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation | |
| CN117304281B (zh) | 一种重组rsv f蛋白及其应用 | |
| AU2012300934A1 (en) | Cyclosporin derivatives | |
| KR20150124999A (ko) | 암 표적화 치료용 알부민-결합 아르기닌 데이미나제를 포함하는 약제학적 조성물 | |
| JP2014506450A5 (https=) | ||
| KR20150132126A (ko) | 화학적 가교결합제 | |
| CN109384839B (zh) | 胰高血糖素样肽-1类似物及其用途 | |
| JPH02500517A (ja) | ペプチド化合物 | |
| WO2014082080A2 (en) | Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases | |
| JPS6084298A (ja) | 新規生理活性ポリペプチドおよびその製造法 | |
| CN108341880A (zh) | 含有胰高血糖素样肽-1和胰高血糖素的片段类似物的嵌合多肽及其用途 | |
| EP3210995B1 (en) | Hemagglutinin-binding peptide | |
| JP2015522532A (ja) | ＴＮＦ−α阻害剤としてのＴＡＣＥプロドメインの変異体およびその医学的使用 | |
| CN103288968B (zh) | 一种抗肿瘤靶向复合物及其制备方法和应用 | |
| CN108341879A (zh) | 一种嵌合多肽及其用途 | |
| ES2537701T3 (es) | Un método de hidrólisis de péptidos, uso de una composición como agente bacteriostático y bactericida y los usos de la forma activa de LytM de S. aureus |